1. Mechanisms of Neuronal Alternative Splicing and Strategies for Therapeutic Interventions
- Author
-
Elizabeth A. Heller, Eduardo Javier López Soto, Sika Zheng, Thomas Gonatopoulos-Pournatzis, Michael J. Gandal, and Diou Luo
- Subjects
0301 basic medicine ,Gene isoform ,Autism Spectrum Disorder ,RNA Splicing ,Biology ,Axonogenesis ,Muscular Atrophy, Spinal ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Animals ,Humans ,Protein Isoforms ,Neurons ,Mammalian nervous system ,General Neuroscience ,Symposium and Mini-Symposium ,Alternative splicing ,Spinal muscular atrophy ,medicine.disease ,Phenotype ,Chromatin ,Alternative Splicing ,030104 developmental biology ,RNA splicing ,Neuroscience ,030217 neurology & neurosurgery - Abstract
Many cellular and physiological processes are coordinated by regulatory networks that produce a remarkable complexity of transcript isoforms. In the mammalian nervous system, alternative pre-mRNA splicing generates functionally distinct isoforms that play key roles in normal physiology, supporting development, plasticity, complex behaviors, and cognition. Neuronal splicing programs controlled by RNA-binding proteins, are influenced by chromatin modifications and can exhibit neuronal subtype specificity. As highlighted in recent publications, aberrant alternative splicing is a major contributor to disease phenotypes. Therefore, understanding the underlying mechanisms of alternative splicing regulation and identifying functional splicing isoforms with critical phenotypic roles are expected to provide a comprehensive resource for therapeutic development, as illuminated by recent successful interventions of spinal muscular atrophy. Here, we discuss the latest progress in the study of the emerging complexity of alternative splicing mechanisms in neurons, and how these findings inform new therapies to correct and control splicing defects.
- Published
- 2019